Oncomed pharmaceuticals inc (OMED)
CashFlow / Quarterly
Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13
Operating activities
Net loss

-

-

-

-5,574

-

-

-

-22,608

-

-25,862

-27,689

-27,213

-24,778

-24,480

-21,620

-14,529

-15,056

-5,486

-15,597

-13,871

-4,344

-3,485

-9,644

-8,598

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization

403

435

430

423

424

425

433

428

436

448

446

434

427

426

407

383

375

370

357

328

331

346

351

350

Gain on disposal of equipment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

50

0

24

39

-

-

-

-

Stock-based compensation

1,140

1,592

1,832

2,278

2,136

1,953

2,202

3,123

2,356

2,828

2,952

2,995

3,451

2,511

2,417

2,387

1,996

2,001

1,507

690

-

-

-

-

Stock-based compensation

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

265

225

Revaluation of convertible preferred stock warrant liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

560

-426

125

21

Prepaid convertible preferred stock warrant expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

15

1

0

1

Amortization of discount on short-term investments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-38

6

23

-

16

17

10

Changes in operating assets and liabilities:
Accounts receivable and other receivables

8

306

-148

-147

57

-1,642

338

-863

267

227

713

-69,391

-

-

-

-

-

-

-

-

-

-

-

-

Receivable-related parties

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-6

-6

-

-

-

-

-

-

-

-

Accounts receivable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-4,000

Prepaid and other current assets

0

420

-176

-40

-721

-790

17

708

-341

302

-1,030

287

1,492

644

-637

78

-674

741

330

-25

-578

706

2

99

Other assets

-878

-302

62

4

-4

164

-400

-444

269

-9

-479

-160

-397

3

276

-3

3,186

-2,038

-553

186

1,114

-736

469

249

Accounts payable

-1,376

2,182

277

-1,861

1,786

-1,326

-1,805

-980

-546

985

1,239

-3,448

3,118

-2,642

3,063

-1,327

588

749

111

-2,771

3,656

1,289

2

-40

Accrued liabilities

-

783

499

-888

-

-497

-1,491

-1,663

-

-524

-161

-2,046

-

1,967

1,262

-3,358

-5,515

3,137

1,996

206

2,859

1,223

661

1,550

Accrued clinical liabilities

409

-248

-711

-1,148

-4,445

-3,679

-6,150

-3,146

2,123

932

5,150

1,428

1,568

2,585

-511

1,750

-

-

-

-

-

-

-

-

Deferred revenue

-

-

-

-7,849

-

-

-

-5,331

-

-5,273

-5,347

-5,349

66,344

-4,686

-4,687

-4,687

-6,014

-17,015

-6,015

-6,015

152,679

-2,932

5,069

-2,932

Deferred rent

69

270

21

34

186

31

31

600

1,002

-185

-187

-180

-171

-171

-171

-166

-157

-157

-157

-153

-144

-143

-121

-133

Income tax payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-806

806

0

-10,758

-

-

-

-

Net cash used in operating activities

-

-

-

-14,402

-

-

-

-28,978

-

-27,171

-22,801

35,885

-17,729

-25,422

-12,371

-19,616

-15,454

-18,871

-17,605

-32,567

167,349

-13,061

-3,738

-5,956

Investing activities
Purchases of property and equipment

133

239

111

172

101

20

64

400

300

160

182

516

186

143

637

398

493

169

537

610

404

30

45

78

Purchases of short-term investments

4,926

8,017

15,092

54,270

19,874

69,651

27,884

9,967

1

77,647

99,635

30,000

9,986

88,841

19,987

9,992

24,979

128,902

29,984

252,991

5,003

102,244

14,998

10,292

Maturities of short-term investments

19,750

14,867

19,874

69,651

27,884

69,673

47,800

39,854

29,956

33,926

74,846

40,010

34,971

108,909

39,977

29,979

38,986

154,000

44,999

102,272

15,250

25,000

25,000

10,000

Financing activities
Proceeds from issuance of common stock related to the exercise of options and employee stock plan purchases

0

47

1

41

139

466

5

1,733

63

390

46

740

94

522

158

1,004

53

558

556

915

-

-

-

-

Net cash provided by investing activities

-

-

-

15,209

-

-

-

29,487

-

-43,881

-24,971

9,494

24,799

19,925

19,353

19,589

13,544

24,929

14,478

-151,329

9,843

-77,274

9,957

-370

Net cash provided by financing activities

-

-

-

41

-

-

-

1,733

-

63,365

980

740

94

522

158

1,004

53

558

556

915

-

-

-

-

Net decrease in cash and cash equivalents

1,280

-2,155

-3,564

848

-2,600

-16,063

-7,255

2,242

-

-

-

-

7,164

-4,975

7,140

977

-

6,616

-2,571

-182,981

197,839

-5,081

6,236

-6,326

Net increase in cash

-

-

-

-

-

-

-

-

-

-

-

46,119

-

-

-

-

-

-

-

-

-

-

-

-

Supplemental cash flow information:
Accrued liabilities for purchase of property and equipment

-

-

-

82

-

-

-20

30

-

-

-

301

-

-

-

-

-

-

-

-

-

-

-

-